+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

In Vitro Diagnostic Products Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6133222
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The in vitro diagnostic products market is rapidly transforming, shaped by technological innovation, regulatory changes, and increasing demands for accurate, early disease detection. Senior leaders must synthesize multi-dimensional intelligence to ensure investments align with emerging opportunities within this dynamic industry.

Market Snapshot: In Vitro Diagnostic Products

Global healthcare systems have intensified their focus on precision medicine, amplifying the role of in vitro diagnostic products as decision-making tools in clinical practice. Market growth is propelled by advancements in molecular diagnostics, digital integration, and evolving reimbursement models. The landscape is defined by accelerated regulatory approvals and increasing adoption of next-generation sequencing, driving changes across diagnostic workflows. Strategic alliances—spanning device manufacturers, reagent developers, and digital health companies—are further consolidating competitive advantage, resulting in greater interoperability and comprehensive diagnostic ecosystems.

Scope & Segmentation of the In Vitro Diagnostic Products Market

  • Product Types: Instruments (Automated Analyzers, PCR Systems, Point of Care Instruments, Sequencing Systems), Reagents (Clinical Chemistry, Hematology, Immunoassay, Microbiology, Molecular Diagnostics), Services (Laboratory Services, Technical Support), Software (Data Management, Diagnostic Imaging).
  • Technology Categories: Clinical Chemistry (Automated Chemistry, Point of Care Chemistry), Hematology (Automated Hematology, Flow Cytometry), Immunoassay (Chemiluminescence, ELISA, Fluorescence Immunoassay), Microbiology (Culture-Based, MALDI-TOF), Molecular Diagnostics (Isothermal Amplification, Next Generation Sequencing, Digital PCR, Real Time PCR).
  • Applications: Cardiology, Diabetes, Infectious Diseases (Bacterial, Parasitic, Viral), Oncology (Hematological Malignancies, Solid Tumors).
  • End Users: Academic and Research Institutes, Clinical Laboratories, Hospitals, Point of Care Settings, Research Laboratories.
  • Test Modes: Central Laboratory Testing, Near Patient Testing, Point of Care Testing.
  • Regions and Countries: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Company Coverage: F. Hoffmann-La Roche AG, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., bioMérieux SA, Becton, Dickinson and Company, QIAGEN N.V., Sysmex Corporation, Bio-Rad Laboratories, Inc.

Key Takeaways for Decision-Makers

  • Integrated diagnostic ecosystems are overtaking standalone solutions, emphasizing interoperability and seamless data connectivity in response to shifting clinical demands.
  • Molecular diagnostics, including isothermal amplification and sequencing, continue to outpace conventional methods, driving specificity and broadening the range of clinically actionable insights.
  • Regulatory pathways are being reshaped, facilitating faster market entry while maintaining quality, encouraging manufacturers to adopt proactive compliance and accelerate product development cycles.
  • Strategic collaborations with software providers and digital health innovators are unlocking new service models such as predictive maintenance and advanced analytics, reinforcing vendor differentiation.
  • Segment-specific requirements vary widely, from point of care settings requiring rapid, flexible instrumentation to central laboratories focused on throughput and multi-analyte capabilities.
  • Regional nuances, such as cost containment in the Americas or robust investment in local manufacturing in Asia-Pacific, necessitate tailored geographic approaches for sustained growth.

Tariff Impact Considerations

The 2025 United States tariff adjustments have increased costs for critical diagnostic components, pushing manufacturers to explore localized sourcing and alternative supply chain strategies. The impact is most profound in segments dependent on imported reagents and specialized materials, prompting sector-wide efforts to build supply chain resilience and evaluate new regional production models. These shifts are reflected in evolving procurement decisions and long-term trade patterns.

Methodology & Data Sources

This report is built on a combination of in-depth interviews with industry executives, laboratory leaders, and key stakeholders. Proprietary surveys, peer-reviewed literature, regulatory documents, and corporate filings constitute the foundation of the data. Cross-validation and review cycles by domain experts ensure the actionable integrity of each insight.

Why This Report Matters

  • Enables C-level executives and senior managers to align investments with significant technology shifts, regional growth trajectories, and evolving regulatory frameworks.
  • Equips operational leaders with validated intelligence to fortify procurement, supply chain, and strategic innovation decisions in a rapidly evolving marketplace.
  • Supports informed selection and adoption of in vitro diagnostic solutions best suited to specific clinical, regulatory, and commercial environments.

Conclusion

As the in vitro diagnostic products industry continues to diversify and adapt, actionable strategies focused on innovation, resilience, and collaborative growth remain essential. Staying ahead requires vigilance, adaptability, and precise, data-driven decisions.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence algorithms into in vitro diagnostic platforms for predictive analytics
5.2. Development of multiplexed point of care molecular assays enabling simultaneous pathogen detection in minutes
5.3. Adoption of microfluidic lab on a chip technologies for rapid high throughput sample processing in clinical labs
5.4. Expansion of next generation sequencing based liquid biopsy tests for early cancer detection and treatment monitoring
5.5. Growth of digital pathology solutions combining whole slide imaging with cloud based diagnostic workflows and AI driven analysis
5.6. Emergence of cost effective CRISPR based diagnostic kits for rapid infectious disease screening in decentralized settings
5.7. Increasing regulatory approvals for companion diagnostic assays linked to targeted oncology therapies across global markets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. In Vitro Diagnostic Products Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Automated Analyzers
8.2.2. PCR Systems
8.2.3. Point Of Care Instruments
8.2.4. Sequencing Systems
8.3. Reagents
8.3.1. Clinical Chemistry
8.3.2. Hematology
8.3.3. Immunoassay
8.3.4. Microbiology
8.3.5. Molecular Diagnostics
8.4. Services
8.4.1. Laboratory Services
8.4.2. Technical Support
8.5. Software
8.5.1. Data Management
8.5.2. Diagnostic Imaging
9. In Vitro Diagnostic Products Market, by Technology
9.1. Introduction
9.2. Clinical Chemistry
9.2.1. Automated Chemistry
9.2.2. Point Of Care Chemistry
9.3. Hematology
9.3.1. Automated Hematology
9.3.2. Flow Cytometry
9.4. Immunoassay
9.4.1. Chemiluminescence
9.4.2. ELISA
9.4.3. Fluorescence Immunoassay
9.5. Microbiology
9.5.1. Culture Based
9.5.2. MALDI TOF
9.6. Molecular Diagnostics
9.6.1. Isothermal Amplification
9.6.2. Next Generation Sequencing
9.6.3. PCR
9.6.3.1. Digital PCR
9.6.3.2. Real Time PCR
10. In Vitro Diagnostic Products Market, by Application
10.1. Introduction
10.2. Cardiology
10.3. Diabetes
10.4. Infectious Diseases
10.4.1. Bacterial
10.4.2. Parasitic
10.4.3. Viral
10.5. Oncology
10.5.1. Hematological Malignancies
10.5.2. Solid Tumors
11. In Vitro Diagnostic Products Market, by End User
11.1. Introduction
11.2. Academic And Research Institutes
11.3. Clinical Laboratories
11.4. Hospitals
11.5. Point Of Care Settings
11.6. Research Laboratories
12. In Vitro Diagnostic Products Market, by Test Mode
12.1. Introduction
12.2. Central Laboratory Testing
12.3. Near Patient Testing
12.4. Point Of Care Testing
13. Americas In Vitro Diagnostic Products Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa In Vitro Diagnostic Products Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific In Vitro Diagnostic Products Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche AG
16.3.2. Abbott Laboratories
16.3.3. Siemens Healthineers AG
16.3.4. Danaher Corporation
16.3.5. Thermo Fisher Scientific Inc.
16.3.6. bioMérieux SA
16.3.7. Becton, Dickinson and Company
16.3.8. QIAGEN N.V.
16.3.9. Sysmex Corporation
16.3.10. Bio-Rad Laboratories, Inc.
17. ResearchAI18. ResearchStatistics19. ResearchContacts20. ResearchArticles21. Appendix
List of Figures
FIGURE 1. IN VITRO DIAGNOSTIC PRODUCTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. IN VITRO DIAGNOSTIC PRODUCTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. IN VITRO DIAGNOSTIC PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. IN VITRO DIAGNOSTIC PRODUCTS MARKET: RESEARCHAI
FIGURE 26. IN VITRO DIAGNOSTIC PRODUCTS MARKET: RESEARCHSTATISTICS
FIGURE 27. IN VITRO DIAGNOSTIC PRODUCTS MARKET: RESEARCHCONTACTS
FIGURE 28. IN VITRO DIAGNOSTIC PRODUCTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. IN VITRO DIAGNOSTIC PRODUCTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY AUTOMATED ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY AUTOMATED ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY POINT OF CARE INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY POINT OF CARE INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SEQUENCING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SEQUENCING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNICAL SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNICAL SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY AUTOMATED CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY AUTOMATED CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY POINT OF CARE CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY POINT OF CARE CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY AUTOMATED HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY AUTOMATED HEMATOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CULTURE BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CULTURE BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MALDI TOF, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MALDI TOF, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PARASITIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PARASITIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY VIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY POINT OF CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY POINT OF CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CENTRAL LABORATORY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CENTRAL LABORATORY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY NEAR PATIENT TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY NEAR PATIENT TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 221. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 224. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 225. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 226. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 227. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 228. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 229. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 230. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 231. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 232. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 233. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 234. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 235. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 236. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 237. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 238. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 239. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2018-2024 (USD MILLION)
TABLE 240. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2025-2030 (USD MILLION)
TABLE 241. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 242. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 243. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 244. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 245. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 248. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 249. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 250. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 251. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 254. CANADA IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 255. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 258. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 259. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 260. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 261. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 262. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 263. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 264. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 265. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 266. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 267. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 268. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 269. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 270. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 271. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 272. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 273. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2018-2024 (USD MILLION)
TABLE 274. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2025-2030 (USD MILLION)
TABLE 275. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 276. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 277. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 278. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 279. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 282. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 283. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 284. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 285. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 288. MEXICO IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MICROBIOLOGY, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL IN VITRO DIAGNOSTIC PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL IN VITRO DIAGNOST

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this In Vitro Diagnostic Products Market report include:
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Becton, Dickinson and Company
  • QIAGEN N.V.
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.